Category: Harm Reduction

2023 WHO Report Wrongly Details Malaysia Policy

Media has reported that the recent World Health Organization (WHO) 2023 report on the global tobacco epidemic wrongly claims Malaysia doesn’t have or barely has smoking bans in public places. Malaysia is marked as having “zero” indoor places with a complete smoking ban. Malaysia has had smoke-free places since 2004.
The WHO Report on the global tobacco epidemic 2023 launched yesterday – which covered data until 2022 – categorised Malaysia as having a “complete absence of a smoking ban, or up to two public places completely smoke-free,” according to media reports.
Other smoking ban categories in the WHO report were three to five public places completely smoke-free, six to seven public places completely smoke-free, and all public places completely smoke-free (or at least 90 per cent of the population covered by complete subnational smoke-free legislation).
Malaysia’s level of compliance with smoking bans was categorized as “data not required or not applicable”.
Going into further detail on public places with complete smoking bans, Malaysia was marked as having “zero” indoor places with a complete smoking ban, as well as having seven outdoor places where smoking is banned either fully or partially.
The 2023 tobacco epidemic report by the United Nations health agency claimed that Malaysia does not have smoking bans in government facilities, indoor offices and workplaces, and pubs and bars.
On health care facilities, educational facilities except for universities, universities, restaurants, and public transport, the WHO report categorized Malaysia with “no” ban, but with an additional tag: “Smoking is banned and the law does not allow designated smoking rooms, except if the health authority allows them by administrative act. Until now, no such administrative act has been taken”.
Malaysia did not receive a single “yes” in the WHO report across all eight categories of public places on whether there is a complete smoking ban. Compliance levels with smoking bans in Malaysia for all these categories were marked as “data not required or not applicable”.
Other countries in the Western Pacific region, in which Malaysia was categorized, received “yes” in various different categories of public places on whether there are smoking bans.
The WHO report also stated that for Malaysia, smoking is not comprehensively banned in one or more jurisdictions.
In another table comparing countries on additional public places with complete smoking bans, again, the WHO report marked “no” for Malaysia in all categories except one — outdoor children playgrounds or parks — that got a “yes”.
The “no” for Malaysia with a tag — “Smoking is banned and the law does not allow designated smoking rooms, except if the health authority allows them by administrative act. Until now, no such administrative act has been taken” — was marked for these categories: land transport (train, taxi, bus, metro, tram); air transport (plane); water transport (boat, vessel, ferry); indoor waiting areas of public transport (train station, metro station etc.); airports; hotels; prisons; shops (supermarket, shop, shopping mall); and cultural facilities (museum, cinema, theatre, arena). Other countries, on the other hand, obtained a “yes” for various different categories.
On additional characteristics of smoking bans, the WHO report marked “yes” for Malaysia on the requirement to display non-smoking signs in smoke-free places; fines on the establishment for not asking a patron to stop smoking and for not posting no-smoking signs; fines on the patron for smoking; and a citizen complaints and investigations system.
Malaysia was marked “no” for required signs identify a telephone number or other mechanisms for the public to report violations; fines on the establishment for not removing ashtrays; and dedicated funds for enforcement. “No explicit ban on use” was marked for Malaysia for the categories of ban on the use of heated tobacco products (HTPs) and electronic nicotine delivery systems (ENDS) or electronic non-nicotine delivery systems (ENNDS) in public places.
This table on additional characteristics of smoking bans appears to be mostly accurate for Malaysia, except for the ashtray component. Eateries in Malaysia are prohibited from providing ashtrays.
On “no explicit ban on use” of e-cigarettes in public places, although Malaysian health authorities do sometimes take action against people for vaping in no-smoking areas, this is not explicitly prohibited in the law, as the Control of Tobacco Product Regulations only covers cigarettes and conventional tobacco products.
Malaysia has had smoke-free places for nearly two decades since the enactment of the Control of Tobacco Product Regulations 2004 under the Food Act 1983. Section 11 of the 2004 regulation itself prohibits smoking in government premises, air-conditioned eateries, shopping complexes, hospitals or clinics, educational institutions or higher educational institutions, airports, and public vehicles or public transport terminals, among others. Designated smoke-free zones have been increased in Malaysia over the years in amendments to the 2004 regulation.
According to an update as of 2020 by Tobacco Control Laws – a website by U.S.-based International Legal Consortium, a team of lawyers who specialize in tobacco control – Malaysia is 100 percent smoke free in multiple indoor places, including public transport, government facilities, health care facilities, schools and universities, and restaurants, among others.
In 2019, then-Health Minister Dzulkefly Ahmad expanded the smoking ban from indoor restaurants to open-air eateries.
August 1, 2023
Activists Slam Latest WHO Report as Misguided

Photo: Tom
The World Health Organization’s recently published report on the global tobacco “pandemic” discounts the impact of harm reduction and vaping, according to Michael Landl, director of the World Vapers’ Alliance
“While filled with biased anti-vaping scaremongering and unfounded claims, the report’s overall direction is perplexing. Instead of prioritizing the crucial goal of reducing smoking rates, the WHO is directing its focus on vaping, which happens to be the most potent smoking cessation tool available.”
In the report’s foreword, Director-General Tedros Adhanom Ghebreyesus asserts that vaping would undermine anti-smoking efforts, claiming that e-cigarettes are harmful to both the people using them and those around them.
“Regrettably, the WHO appears to ignore reality and scientific evidence,” said Landl in a statement. “Countries that adopt an open and consumer-friendly approach to harm reduction products achieve significantly better results than those following WHO’s misguided path. Comparative data from Sweden and the United Kingdom demonstrate their remarkable success in reducing smoking rates, surpassing countries with a negative harm reduction approach by a wide margin.”
The WHO report also claims a gateway effect from vaping to smoking and alleges that vaping flavors target children. It further highlights that 121 countries have adopted vaping regulations, with 34 completely banning vape sales.
“The outdated and debunked theories propagated by the WHO report pose risks to public health,” said Landl. “The notion of a gateway effect from vaping to smoking lacks evidence. Furthermore, flavors are essential for adults as they play a crucial role in helping millions of smokers transition to vaping. Additionally, celebrating countries which ban a way less harmful alternative for smokers is absurd.”
According to a review of 15 studies, “a true gateway effect in youths has not yet been demonstrated,” according to Landl. Factors such as anxiety, parental smoking habits, peer attitudes and household income must be considered, he noted. Another study found that vaping is not a gateway to smoking but rather that negative circumstances in teenagers’ lives lead to risky behaviors. According to the Yale School of Public Health, vaping flavored e-cigarettes is linked to a 230 percent increase in adult smoking cessation, and a flavor ban, as suggested by the WHO, could drive five out of 10 vapers back to smoking or the black market.
“The lack of empathy for smokers and vapers, coupled with the outright denial of scientific findings, will have severe consequences for many lives,” said Landl. “The WHO seems to have lost sight of its ultimate goal – reducing smoking rates. While we all agree that teenagers should not smoke or vape, the report notes that only 45 percent of countries ban e-cigarette sales to minors, and 10 percent of countries impose no age restrictions on cigarette purchases. Why not address these real-life challenges? The WHO systematically disregards an abundance of scientific evidence supporting the benefits of vaping, not to mention the experiences of millions of vapers. Vaping is 95 percent less harmful than smoking and a more effective method to quit smoking compared to traditional products like gum and patches. Restricting or banning access to vaping will only lead to unnecessary loss of lives.”
August 1, 2023
Bangladesh Mayors Commit to Smoke-Free Future

Mayors from Bangladesh’s municipalities met for a two-day summit with national and international tobacco control experts, where they pledged to aim for Prime Minister Sheikh Hasina’s vision of a tobacco-free Bangladesh by 2040, reports the Dhaka Tribune.
The goal of the summit was to discuss implementation of tobacco control laws and local government guidelines. The country’s tobacco control law was enacted in 2005 after ratification of the World Health Organization Framework Convention on Tobacco Control. The law was amended in 2013, introducing pictorial health warnings and including smokeless tobacco. It took over three years to put the law into practice, and during that time, the health ministry drafted an amendment banning vaping products, lifting the provision of designated smoking zones to prevent secondhand smoke and controlling point-of-sale advertising. The draft is pending Cabinet approval.
Tobacco use is not declining as expected, according to anti-tobacco activists. The latest data shows that 35.3 percent of adults ages 18 and older used tobacco in any form in 2017. Experts warn that if the trend continues, the tobacco-free goal will not be met.
“The key is to have strong local leadership in terms of policy development, policy implementation and mobilizing funds at the local level for the prevention of tobacco use and noncommunicable diseases,” said Tara Singh Bam, regional director of The Union Asia Pacific, who spoke at the summit. “Mechanisms need to be established that ensure mayors are held accountable for safeguarding the development and implementation of public health policies from the undue influence of unhealthy commodity industries.”
“We, the Ministry of Local Government, issued tobacco guidelines for all the municipalities and cities to assist them,” said Joint Secretary Jasim Uddin. “We have distributed these guidelines.” He noted that the mayors attending the summit are “very committed” to preventing tobacco-related diseases and deaths.
The guidelines direct the mayors to improve tobacco control law enforcement, build public awareness, allocate funds for tobacco control and limit the availability of tobacco products.
July 24, 2023
Activists Dispute Smoking Gateway Findings

Photo: Wlodzimierz
Recent claims by Otago University in New Zealand that vaping is a gateway to smoking have been disputed by leading global harm reduction experts Roberto Sussman, Konstantinos Farsalinos and Gerry Stimson. These experts have highlighted the importance of harm reduction strategies in reducing the negative health impacts of smoking.
Published on June 28 in Drug and Alcohol Review, the Otago University study analyzed data related to New Zealanders’ smoking and vaping status from the 2018-2020 New Zealand Attitudes and Values survey.
Unlike other studies, Post-graduate student Andre Mason and associate professor Damian Scarf found no consistent evidence that vaping acted as a cessation pathway from smoking. Mason said vaping appeared to be another smoking-related behavior, rather than a substitute for smoking that primarily helped people quit.
“We found that there was an equal likelihood of vapers transitioning to smoking as smokers were to vapers,” Mason told Radio New Zealand.
Tobacco harm reduction advocates questioned the findings. According to Sussman, there is no evidence that vaping is a gateway to smoking. “In fact, studies have shown that vaping can be an effective tool for smoking cessation,” he said. “The vast majority of vapers are former smokers who have successfully quit smoking thanks to vaping,” added Farsalinos
Gerry Stimson, a public health expert and advocate for harm reduction, emphasizes that harm reduction strategies like vaping are essential in reducing the negative health impacts of smoking. “We need to focus on providing smokers with safer alternatives to cigarettes, rather than demonizing harm reduction strategies like vaping,” he noted.
Nancy Loucas, executive coordinator of the Coalition of Asia Pacific Tobacco Harm Reduction Advocates, who compiled these comments, also disputed the gateway claim by Otago University.
Lous cited recent data, which suggest the smoking incidence rates in New Zealand have fallen significantly over the past five to 10 years. The current smoking rate of New Zealand adults is 8 percent in 2021/2022, which has decreased from 16.5 percent in 2015 and from 27 percent in both men and women in 1993. Loucas insists that vaping has played a significant role in the reduction of smoking rates in New Zealand over the past five to 10 years. According to research published in the NZ Medical Journal, the current vaping rate in New Zealand is 8.3 percent of adults being categorized as daily e-cigarette users, up from 6.2 percent in the previous year.
“We need to focus on harm reduction strategies that work, rather than relying on outdated and inaccurate claims about vaping being a gateway to smoking,” said Loucas. “The evidence is clear: vaping can be an effective tool for smoking cessation and harm reduction.
The government of New Zealand has given NZD1.4 million ($860,411) to a large trial to help New Zealanders quit vaping. Over six months, more than 1,000 participants will test whether cytisine—a medicine that partially blocks the effects of nicotine on the brain—is more effective than a tapered reduction in nicotine, when accompanied with behavioral support.
July 6, 2023
Doctor’s Orders
Photo: Minerva Studio
Medical licensing of e-cigarettes and nicotine pouches should be an urgent priority.
By Derek Yach
The alarm about the risks of products to health is usually first sounded by physicians. That was certainly the case with tobacco and health. The 1962 Royal College of Physicians (RCP) Report on Smoking as well as the 1964 Surgeon General’s (SG) Report on the same topic were led by physicians and drew upon the best epidemiological evidence available. The reports’ statement that “smoking kills” led to rapid changes in physicians’ smoking behavior well before regulators took up the challenge. The world had to wait eight years before the World Health Organization passed its first modest resolution on smoking. Only then did modest public health policies emerge.
Internationally, the evidence is clear: No country experiences a serious decline in their smoking rates before it declines among physicians. And it takes about a decade before the population benefits start appearing. Globally, smoking rates among men approach 40 percent to 50 percent in countries as diverse as China, Bulgaria, Jordan and Bangladesh—or 50 years behind where the U.K. is today. Smoking rates among the physicians in these countries are about the same. There are few examples of physician-led reports like those of the RCP or SG from middle-income or lower middle-income countries. In such settings, we cannot expect to see substantial progress in ending smoking if we stick with the status quo.
Physician Leadership Is Crucial for the Introduction of Innovative Interventions
Innovations in healthcare are usually led by physicians armed with solid epidemiological and clinical data showing the benefits of new interventions for patients and the population. Physician leadership gives credibility to new products. The opposite is also true. Products that are not endorsed or approved by physicians rarely achieve population benefits and may face stiff regulatory approval.
Sluggish Progress on Improving Cessation Outcomes
For decades, physicians have followed a “medicalization” path to cessation, so it is not surprising that they have neglected tobacco harm reduction (THR) options. The basic advice given by physicians has changed little. Quit cold turkey, counseling, nicotine-replacement therapies (NRTs) and a few other pharmaceutical and behavioral services remain the mainstay of cessation. None have success rates that exceed 15 percent over the year, and most are associated with repeated relapses. The World Health Organization’s own reports to the World Health Assembly this year pointed to slow progress in addressing cessation. Numerous reports, such as those issued by the Foundation for a Smoke-Free World, have pointed to the failure of the pharmaceutical industry to bring better cessation tools to the market despite advances in behavioral and neuroscience that have led to new therapies for a range of diseases.
It is long overdue that physicians have access to far more efficacious and effective ways of ending smoking. We now have a full range of feasible options that have been authorized by the U.S. Food and Drug Administration as “appropriate for the protection of public health”: heated-tobacco products, e-cigarettes, snus and most recently nicotine pouches. E-cigarettes and nicotine pouches are well placed to form the basis of a new approach to cessation and harm reduction.
How Do We Engage Physicians in Scaling up Access to These Lifesaving Products?
Recent experience shows that physicians have been resistant to these products for several reasons. They fear these are a new tactic by the tobacco industry to keep the next generation addicted. They seek data on long-term benefits. They are bamboozled daily by well-funded nonprofits and WHO messages about the dangers of these products for kids, and the impact of them on cancer or heart disease. The fact that none of this is based on science has not stopped the opposition.
Could Medically Licensed Products Break Through and Reach Physicians?
I strongly believe that they could.
At a recent Keller and Heckman meeting, Ian Fearon, chief scientific officer at McKinney Scientific Advisors, described the “halo” effect of having medically licensed e-cigarettes on the market. To get medically licensed requires proof of quality, safety and efficacy. Once achieved, this could legitimize the category and open the doors to widespread physician acceptance of the products. The same could happen with nicotine pouches.
This could start to erode distrust of these products by physicians as they use them and advise their patients to use them. The predictable positive outcomes would accelerate adoptions and use.
Recall that almost 50 percent of male doctors in many low-income and middle-income countries and countries across the Middle East smoke. Helping them to switch first deserves concerted effort. And having a new medically licensed e-cigarette or nicotine pouch could well trigger the desired cascading impacts on their patients and then among the general population.
The process to obtain a medical license has been well outlined by the FDA’s Center for Drug Evaluation and Research (CDER) and the U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA). Neil Benowitz et al. (see below) and Fearon have stressed that CDER requirements are particularly onerous. The MHRA process is more “encouraging.” According to them, a major benefit of the MHRA is that studies required can be conducted in any country whereas only U.S. studies are accepted by the CDER.
A unique authoring partnership between people who usually disagree about the value of THR concluded that the CDER should “reach out to companies that may be interested in developing smoking cessation products” and indicated that that could include medically approved vapes. Authors included Benowitz and Ken Warner, known supporters of THR, and Matt Myers and Joanne Cohen, who until now have opposed THR.
They commented that “the deadliest form of nicotine delivery has been subject to limited oversight whereas products marketed to help people quit face far more regulatory barriers.” The fact that agreement can be reached on the value of THR in the context of medically licensed products should be taken as a signal to how broader acceptance might happen.
Mitch Zeller, previous head of the FDA’s Center for Tobacco Products, jumped into this field recently and urged action on medical licensing when he announced that he had joined a company aiming to bring a medically licensable vape to market.
Why Has Industry Not Led the Way?
There can be little doubt that the pharmaceutical industry and leaders in the tobacco industry have long had the scientific knowledge and technical capabilities to develop medically licensed equivalents to e-cigarettes and nicotine pouches. So why has there been no progress? Are short-term commercial interests taking precedent over health needs? I suspect this is a major factor delaying progress by large companies. But thankfully, smaller entrepreneurial companies are pursuing medical licenses at considerable cost to them.
In addition to commercial interests, industry leaders and analysts have mentioned three other issues as hampering to progress:
Concern that the WHO and anti-harm reduction activists would mount campaigns against them.
Tobacco companies fear that a medically licensed product would reach a small part of the market—people with early symptoms of disease or those deeply concerned about their health. That might turn off other smokers seeking to use safer products for recreation and pleasure. They do not want to be stigmatized as being “patients.”
Any innovation or improvement to a medically licensed reduced-risk product needs costly, lengthy and comprehensive re-appraisals by the regulating body with no guarantee of consumer acceptance. For industries specializing in fast-moving consumer goods, this can be a deterrent.
What Is the Size of the Market?
Companies need to look at data on the burden of disease and at data they have showing that an extremely high percentage of e-cigarette users switched from combustibles for health reasons. Global burden of disease data shows that 8 million people die annually from tobacco use. That figure hides the fact that hundreds of millions of tobacco users have early symptoms or signs of cancers, heart and lung disease or tuberculosis. It hides the fact that over 50 percent of people with serious mental illness smoke, that about 60 percent to 70 percent of people with early chronic obstructive pulmonary disease, tuberculosis and schizophrenia smoke at the point they are diagnosed. And that figure does not change much during their treatment, suggesting physicians’ failure to help their patients end smoking.
It is not surprising that a recent Bloomberg analysis suggests that the size of the nicotine-replacement market could reach $100 billion by 2028. That should stimulate companies to invest in medically licensed options that consumers demand and enjoy in unprecedent numbers.
How Would These Products Be Marketed?
Marketing strategies would need to distinguish between products that are medically approved versus others. There are many precedents for designing marketing plans to reach two different audiences using the same basic product. The most recent being how Ozempic addresses the needs of people with diabetes while Wegovy (both made by Novo Nordisk) addresses obesity. Two brands, one set of active ingredients. In an analogous way, initially NRTs were prescription-only in most countries but were changed to “over the counter” use to improve access to “essential medicine,” and NRTs are noted as such in the WHO Model List of Essential Medicines.
I could see this developing a comparable way for e-cigarettes and nicotine pouches.
Conclusion
There is a massive untapped need to get more efficacious cessation products on the market. Medically licensed e-cigarettes and nicotine pouches could well be the key to gaining widespread and critically needed physician support for the categories. That could unblock deep opposition to THR as it has happened with so many innovations that benefit health.
A global health expert and anti-smoking advocate for more than 30 years, Derek Yach is the owner of Global Health Strategies. Previously, Yach was the director of the Foundation for a Smoke-Free World and a World Health Organization cabinet director and executive director for noncommunicable diseases and mental health. He was deeply involved with the development of the Framework Convention on Tobacco Control.
June 19, 2023
Nine Groups Sign Letter to End Tobacco Prohibitions

Image: Tobacco Reporter archive
Nine advocacy groups, including Americans for Tax Reform, have signed a letter supporting proposed legislation that would deny the U.S. Food and Drug Administration funds to implement its plans for nicotine levels and menthol flavors.
Sections 768 and 769 of the Fiscal Year 2024 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations bill ensure that no funds provisioned by the bill can be used to implement a maximum nicotine level for cigarettes, to prohibit menthol flavors for cigarettes or cigars or other special flavors for cigars.
The letter notes the impact that tax hikes and bans can have on smuggling and organized crime and warns about a possible expansion of the black market. It also advocates for educating consumers to better empower them to make educated choices.
“The protections included in Sections 768 and 769 of this bill would prevent overreach by regulators that would have significant negative impact on taxpayers, farmers, retailers, consumers, manufacturers, state and local governments and supply chains across the country,” the letter states.
June 9, 2023
New Zealand Readies to Address Youth Vaping

Image: Tobacco Reporter archive
New Zealand Health Minister Ayesha Verrall is set to unveil the government’s strategy to address youth vaping, reports Stuff.
While an outright ban on cheap, disposable vapes or making them prescription-only has not been promised, Verrall aims to strike a balance between using vaping as a smoking cessation tool and preventing its appeal to young people.
The Australian government recently banned the importation of vapes except through pharmacies and introduced quality standards. Verrall did not confirm if New Zealand would follow suit, but she emphasized the need for a vaping policy that aligns with the country’s specific needs.
Proposed regulations include restricting the location of specialist vape retailers near schools or sports grounds, regulating vape flavor names and implementing safety measures for single-use vaping products. Some experts suggest further measures, such as educating young people and limiting availability to pharmacies.
The regulation of vaping products and retailers was not included in the previously passed legislation to ban tobacco sales to a generation.
The government also plans to reduce the number of places selling tobacco products from 6,000 to 600 as part of their Smoke-Free 2025 action plan.
June 2, 2023
European Elections Could Impact Support of Vaping

Credit: Savvapanf Photo
Elections in several European countries could affect support of reduced-risk nicotine products like e-cigarettes, according to Tamarind Intelligence Policy Radar research.
Governments in Europe are the most likely to officially support reduced-risk products.
According to Tamarind Intelligence, forthcoming elections in Finland, Spain, Ireland and the Czech Republic as well as elections for the European Parliament could be significant in determining the future of the products.
“Our analysis of official attitudes toward e-cigarettes and other tobacco harm reduction products shows some clear global trends,” said Tamarind Intelligence Editorial Director Barnaby Page. “For example, European countries tend to have more favorable attitudes while Asian countries tend to be much more polarized.
“However, the laws in this area can change very rapidly—sometimes because government itself changes or at other times because issues such as underage vaping or the environmental impact of disposable vapes come into the spotlight.”
Researchers expect worldwide regulation of reduced-risk products to become stricter, especially in upper-middle-income and high-income countries. Flavored products are expected to receive the most attention with countries proposing bans on the products.
June 2, 2023
Knowledge-Action-Change Briefing Explains COP 10

Gerry Stimson | Photo courtesy of GNF
Knowledge Action Change (KAC) has published a briefing to help policymakers, health officials and consumers better understand the Conference of the Parties (COP) to the World Health Organization Framework Convention on Tobacco Control (FCTC). The 10th edition of this event, which normally takes place every two years, is scheduled for November in Panama.
While decisions made at the conference are likely to significantly impact tobacco companies and their customers, industry representatives and organizations advocating for access to safer nicotine products have traditionally been barred from attending the event.
As a result, tobacco harm reduction has been getting short rift at COP meetings despite the fact that the concept is an integral part of the FCTC.
“Harm reduction is explicitly named as one of three tobacco control strategies in the opening lines of the Framework Convention on Tobacco Control, but at present, the indications are that COP10 is unlikely to result in any decisions that support consumer access to safer nicotine products,” said KAC Director Gerry Stimson in a statement.
“Parties to the FCTC must seize the opportunity in Panama to consider evidence from countries where tobacco harm reduction is saving lives, including the U.K., New Zealand, Sweden, Norway and Japan—and ask why the WHO and its influential philanthropic funders are refusing to do the same.
“With no media present, FCTC COP meetings are shrouded in a secrecy more akin to a U.N. Security Council meeting—and in direct contrast to other COP meetings, for example those on climate change. This briefing paper gives policymakers, health officials and consumers more insight into the processes of COP10 and the opportunity to engage more fully prior to and during the event in Panama,” said Stimson
May 15, 2023
FEELM Commends UK Vapor Outlook During GTNF Event

Echo Liu, FEELM’s European Division director
FEELM, the flagship atomization technology brand for Smoore International, the world’s largest vaping company, commended the U.K. Government for the country’s tobacco harm reduction strategy. The U.K.’s vaping outlook centers around the use of vaping as a tool for smoking cessation, and encouraging existing smokers to transition to a less harmful alternative.
Andrew Lewer, Delon Human and Echo Liu
During a breakfast event before the virtual IN FOCUS seminar, an annual half-day event organized by the Global Tobacco and Nicotine Forum (GTNF) that focuses on harm reduction, FEELM representatives spoke in central London alongside Andrew Lewer MBE MP, the vice chair of the U.K. Parliament’s All-Party Parliamentary Group for Vaping, as well as Delon Human, the president of Health Diplomats and a former Secretary-General of the World Medical Association.
The conversations centered on the theme of addressing tobacco harm reduction, and how best to support smokers to transition to reduced-risk products, including vapes, heat-not-burn products, and oral nicotine.
“We welcome the UK Government’s ongoing recognition of the potential that vaping has to achieve its ambitions for a smoke-free future, and we are committed to working with regulators and the wider industry to address the key challenges the sector faces,” said Echo Liu, FEELM’s European Division director. “Our vaping solutions have been widely adopted in more than fifty markets – including the UK, France, and Germany – and these are helping millions of smokers to improve their health by switching to vaping.”
FEELM’s disposable ceramic coil technologies have already been launched in major markets such as France, the U.K. and Belgium, and will soon be available in other key markets, according to a press release.
“The FEELM MAX solution, which offers more puffs, greater taste consistency, and a fully visible e-liquid measure, is the best disposable available which ensures regulatory compliance,” the release states. “FEELM will be launching its FEELM MAX at the Birmingham Vaper Expo on May 13.”
April 26, 2023